Source: Daily Caller (April 28, 2025)
One in ten patients experience a “serious adverse event” after taking the abortion pill, according to a study released Monday by the Ethics and Public Policy Center (EPPC), a conservative think tank and advocacy group.
The study found that 10.93% of women experienced sepsis, infection, hemorrhaging, or another serious adverse event within 45 days after a mifepristone abortion. The real-world rate of serious adverse events after mifepristone abortions is at least 22 times as high as the summary figure of “less than 0.5%” in clinical trials reported on the drug label, according to the study.
Mifepristone, when used together with another medication called misoprostol, is used to have an abortion during the first ten weeks of pregnancy, according to the U.S. Food and Drug Administration (FDA). Danco Laboratories, a pharmaceutical distributor based in Manhattan, distributes mifepristone under the brand name Mifeprex, and claims on their website that the drug is “safe and effective.”
The study, which the EPPC claims to be the largest-known review of the abortion pill conducted in the U.S., is based on analysis of data from an all-payer insurance claims database that includes 865,727 prescribed mifepristone abortions from 2017 to 2023. (RELATED: Blue State Law Lets Abortion Providers Sidestep Accountability When Doling Out Drugs)
“Danco Laboratories markets Mifeprex as ‘the safe and effective abortion pill,’ but our research shows that mifepristone abortion, as currently practiced in the U.S., is not safe and effective,” the EPPC wrote in the study. “The manufacturer and the FDA rely on the results of 10 clinical trials with a total of 30,966 participants, less than 0.5% of whom reportedly experienced serious adverse reactions. In contrast, we analyzed real-world insurance claims data for 865,727 prescribed mifepristone abortions, broadly representative of women who obtain mifepristone abortions in the U.S. today, and we find a serious adverse event rate of 10.93%—at least 22 times as high as the summary figure reported on the drug label.”
A similar study released by the Foundation for the Restoration of America (FFROA) on April 25 also found that more than 10% of women who underwent a mifepristone abortion “experience a serious adverse event.”
FFROA founder Doug Truax, who commissioned the study, told the DCNF in a statement: “These shocking findings should alert all women that the abortion pills are extremely dangerous to their well-being — a conclusion completely at odds with what the FDA tells us. Once again, we are learning that our government will put political ideology above science, data, and the health and safety of its citizens.”
“This bombshell report is further evidence that our government uses phony data and politicized science to lie to its people. In this case, those lies further political ideologies rather than the health, safety, and well-being of women and children,” Truax added.